Tag Archives: metabolic risk

Continuous ketone monitoring is gaining attention as a promising tool for detecting metabolic risk earlier than traditional methods. While glucose monitoring has long been the standard, ketones offer another layer of insight into how the body processes energy. Could this emerging technology reshape how clinicians assess risk and guide treatment …

For years, GLP-1 receptor agonists have been associated with older adults who already have type 2 diabetes or established cardiovascular disease. However, metabolic dysfunction does not suddenly appear at age 60. In fact, obesity, insulin resistance, and prediabetes often begin decades earlier. That is why conversations around GLP-1 therapy in …